FindTrial
Sign In

Disease causing ability, and medical effects of bacterial infections in ICU to understand challenges and opportunities for prevention.

Pathogenicity,resistance attributes and clinical impact of Acinetobacter baumannii complex infections in ICU settings to understand challenges and opportunities for prevention.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/035228
Enrollment
163
Registered
2021-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B968- Other specified bacterial agents as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Manipal Academy of Higher Education Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult inpatients with blood culture positive for Acinetobacter baumannii complex admitted in Kasturba Hospital.

Exclusion criteria

Exclusion criteria: Patients known to have confirmed A. baumannii complex bacteremia, prior admission to the hospital.

Design outcomes

Primary

MeasureTime frame
Clinical and epidemiological features associated with the A. baumannii bacteremia and the incidence will be known.Timepoint: 3 years—

Secondary

MeasureTime frame
Molecular basis of drug resistance and the pathogenicity will be learnt Timepoint: 1 year—

Countries

India

Contacts

Public ContactManasa C Tantry

Kasturba Medical College, Manipal

vandanake@gmail.com9902206009

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026